查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511837

美國糖尿病足潰瘍治療市場規模、佔有率、趨勢分析報告：按治療、潰瘍類型、最終用途和細分市場預測，2024-2030 年

U.S. Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy Device, Wound Care Dressing), By Ulcer Type (Ulcer, Neuro-ischemic Ulcer), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

美國糖尿病足潰瘍治療市場成長與趨勢：

根據 Grand View Research, Inc. 的最新報告，預計 2030 年美國糖尿病足潰瘍治療市場規模將達到 24.7 億美元，2024 年至 2030 年複合年成長率為 5.25%。

推動市場開拓的主要因素包括全國糖尿病發病率的上升、人口老化、治療技術的進步、研發力度的加強以及生活方式的改變。例如，人口研究所預測，65歲及以上的美國人數量預計將從2022年的5,800萬增加到2050年的8,200萬，成長47%。

由於糖尿病足潰瘍是一種常見的併發症，美國的糖尿病流行對擴大市場發揮了重要作用。例如，根據國際糖尿病聯盟的數據，2021年美國約有3,221萬人在20歲至79歲之間的糖尿病患者，預計2045年將進一步增加至3,628萬人。此外，醫療技術和治療方法的進步也促進了市場的成長。先進的創傷護理產品、生物工程組織和再生醫學技術等創新為糖尿病足潰瘍管理提供了更有效和高效的解決方案。

此外，醫療保健提供者和患者對糖尿病足潰瘍早期發現和適當治療重要性的認知不斷提高，正在推動市場成長。醫療保健專業人員和患者都知道，早期發現糖尿病足潰瘍需要仔細的足部護理和定期檢查。這種認知的提高促使人們採取積極的方法來管理糖尿病併發症，從而改善患者的治療效果並減少嚴重潰瘍。此外，持續的研究和開發工作對於推進糖尿病足潰瘍的治療選擇和技術至關重要。這些持續的努力帶來了創新的解決方案，包括新的治療方法、診斷工具和預防方法，擴大了醫療保健提供者的選擇範圍。

主要市場參與企業的存在以及每家公司為保持市場競爭力而採取的各種舉措，例如產品核可、產品發布、聯盟、併購和業務擴張，預計將有助於整體市場的成長。例如，2024 年 4 月，Molnlycke Health Care 宣布計劃收購 PGF Industry Solutions GmbH，這是一家以生產傷口清洗和保濕產品 Granudacyn 而聞名的奧地利公司。

美國糖尿病足潰瘍治療市場報告亮點

  • 以治療來看，生物製藥領域將在2023年佔據市場主導地位，銷售佔有率將超過30%。
  • 預計治療設備領域在預測期內將以最快的複合年成長率成長。
  • 按潰瘍類型分類，神經缺血性潰瘍在 2023 年佔據最大市場佔有率。
  • 預計 2024 年至 2030 年，缺血性潰瘍部分將以最快的速度成長。
  • 從最終用途來看，醫院和診所將在 2023 年引領市場。
  • 2023 年，北美佔據市場主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國糖尿病足潰瘍治療市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國糖尿病足潰瘍治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國糖尿病足潰瘍治療市場：治療評估與趨勢分析

  • 細分儀表板
  • 美國糖尿病足潰瘍治療市場：治療變異分析
  • 2018-2030年美國糖尿病足潰瘍治療市場規模及趨勢分析（依治療）
  • 創傷護理敷料
  • 生物製藥
  • 治療設備
  • 抗生素
  • 其他

第5章美國糖尿病足潰瘍治療市場：潰瘍類型估計與趨勢分析

  • 細分儀表板
  • 美國糖尿病足潰瘍治療市場：潰瘍類型變異分析
  • 2018-2030年美國糖尿病足潰瘍治療市場規模及趨勢分析（依潰瘍類型）
  • 2018-2030年市場規模及預測及趨勢分析
  • 神經病變潰瘍
  • 缺血性潰瘍
  • 神經缺血性潰瘍

第6章美國糖尿病足潰瘍治療市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 美國糖尿病足潰瘍治療市場：最終用途變化分析
  • 2018-2030 年美國糖尿病足潰瘍治療市場規模與趨勢分析（依最終用途）
  • 醫院
  • 門診手術中心
  • 居家照護

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率分析
  • 公司定位分析
  • 公司分類（新興企業、創新企業、領導者）
  • 公司簡介
    • ConvaTec, Group Plc
    • 3M Health Care
    • Coloplast Corp.
    • Smith &Nephew Plc
    • B Braun Melsungen AG
    • Medline Industries, LP.
    • Molnlycke Health Care AB
    • Medtronic Plc
Product Code: GVR-4-68040-302-9

U.S. Diabetic Foot Ulcer Treatment Market Growth & Trends:

The U.S. diabetic foot ulcer treatment market size is anticipated to reach USD 2.47 billion by 2030, expanding at a CAGR of 5.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing occurrence of diabetes nationwide, an aging population, advancements in treatment technology, rising research and development efforts, and shifts in lifestyle patterns. For instance, according to the Population Reference Bureau's projections, the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by the year 2050, reflecting a 47% increase.

The prevalence of diabetes in the U.S. plays a significant role in market expansion, as diabetic foot ulcers are a common complication of the disease. For instance, according to the International Diabetes Federation, in 2021 there were about 32.21 million diabetes patients aged 20-79 years in the U.S. which are further expected to increase to 36.28 million by 2045. Furthermore, the advancements in medical technology and treatment modalities contribute to the growth of the market. Innovations such as advanced wound care products, bioengineered tissues, and regenerative medicine techniques offer more effective and efficient solutions for diabetic foot ulcer management.

Furthermore, the increasing awareness among healthcare providers and patients of the importance of early detection and proper treatment of diabetic foot ulcers is driving the market growth. Both healthcare professionals and patients understand the necessity of careful foot care and regular screenings to catch diabetic foot ulcers early. This heightened awareness encourages a proactive approach to managing complications of diabetes, leading to better outcomes for patients and fewer severe ulcers. Additionally, ongoing research and development efforts are essential in advancing treatment options and technologies for managing diabetic foot ulcers. These continued efforts result in innovative solutions, such as new therapies, diagnostic tools, and preventive measures, which expand the options available to healthcare providers.

Presence of major market participants and various initiatives undertaken by them to stay competitive in the market such as product approval, product launch, partnership, merger and acquisition, expansion, etc. are expected to contribute to the overall market growth. For instance, in April 2024, Molnlycke Health Care has announced its plans to acquire P.G.F. Industry Solutions GmbH, an Austrian company known for producing Granudacyn, a line of wound cleansing and moisturizing products.

U.S. Diabetic Foot Ulcer Treatment Market Report Highlights:

  • Based on treatment, the biologics segment dominated the market by capturing a revenue share of more than 30% in 2023
  • The therapy devices segment is anticipated to grow at the fastest CAGR during the forecast period
  • Based on ulcer type, the neuro-ischemic ulcers segment held the largest market share in 2023
  • The Ischemic ulcers segment is expected to grow at a fastest rate from 2024 to 2030
  • Based on end-use, hospitals and clinics led the market in 2023
  • North America dominated the market in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Ulcer Type
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Ulcer type outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of diabetes
      • 3.2.1.2. Aging population
      • 3.2.1.3. Advancements in treatment technology
      • 3.2.1.4. Lifestyle changes
      • 3.2.1.5. Growing R&D activities
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment
  • 3.3. U.S. Diabetic Foot Ulcer Treatment Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global U.S. Diabetic Foot Ulcer Treatment Market Movement Analysis
  • 4.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Wound Care Dressings
    • 4.4.1. Wound care dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Alginate dressings
      • 4.4.1.1.1. Alginate dressing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Hydrofiber dressings
      • 4.4.1.2.1. Hydrofiber dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Foam dressings
      • 4.4.1.3.1. Foam dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.4. Film dressing
      • 4.4.1.4.1. Film dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.5. Hydrocolloid dressings
      • 4.4.1.5.1. Hydrocolloid dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.6. Surgical Dressings
      • 4.4.1.6.1. Surgical dressings market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.7. Hydrogel dressings
      • 4.4.1.7.1. Hydrogel dressings market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Biologics
    • 4.5.1. Biologics market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.5.1.1. Growth factors
      • 4.5.1.1.1. Growth factors market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.5.1.2. Skin grafts
      • 4.5.1.2.1. Skin grafts market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Therapy devices
    • 4.6.1. Therapy devices market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.6.1.1. Negative pressure wound therapy
      • 4.6.1.1.1. Negative pressure wound therapy market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.6.1.2. Ultrasound therapy
      • 4.6.1.2.1. Ultrasound therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Antibiotic medicine
    • 4.7.1. Antibiotic medicine market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global U.S. Diabetic Foot Ulcer Treatment Ulcer Type Market Movement Analysis
  • 5.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by Ulcer Type, 2018 to 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5. Neuropathic Ulcers
    • 5.5.1. Neuropathic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Ischemic Ulcers
    • 5.6.1. Ischemic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Neuro-ischemic Ulcers
    • 5.7.1. Neuro-ischemic ulcers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. U.S. Diabetic Foot Ulcer Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global U.S. Diabetic Foot Ulcer Treatment End Use Market Movement Analysis
  • 6.3. Global U.S. Diabetic Foot Ulcer Treatment Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgery Center
    • 6.5.1. Ambulatory surgery center market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Homecare
    • 6.6.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. ConvaTec, Group Plc
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. 3M Health Care
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Coloplast Corp.
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Smith & Nephew Plc
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. B Braun Melsungen AG
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Medline Industries, LP.
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. Molnlycke Health Care AB
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Medtronic Plc
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. U.S. diabetic foot ulcer treatment market by treatment, 2018 - 2030 (USD Million)
  • Table 4 U.S. U.S. diabetic foot ulcer treatment market by ulcer type, 2018 - 2030 (USD Million)
  • Table 5 U.S. U.S. diabetic foot ulcer treatment market by end use, 2018 - 2030 (USD Million)
  • Table 6 Participant's overview
  • Table 7 Financial performance
  • Table 8 Key companies undergoing expansions
  • Table 9 Key companies undergoing acquisitions
  • Table 10 Key companies undergoing collaborations
  • Table 11 Key companies launching new products/services
  • Table 12 Key companies undergoing partnerships
  • Table 13 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2023 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 US diabetic foot ulcer treatment market: Treatment outlook and key takeaways
  • Fig. 15 US diabetic foot ulcer treatment market: Treatment movement analysis
  • Fig. 16 Wound care dressings market, 2018 - 2030 (USD Million)
  • Fig. 17 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 18 Hydrofiber dressings market, 2018 - 2030 (USD Million)
  • Fig. 19 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 20 Film dressing market, 2018 - 2030 (USD Million)
  • Fig. 21 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 22 Surgical dressings market, 2018 - 2030 (USD Million)
  • Fig. 23 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Biologics market, 2018 - 2030 (USD Million)
  • Fig. 25 Growth factors market, 2018 - 2030 (USD Million)
  • Fig. 26 Skin grafts market, 2018 - 2030 (USD Million)
  • Fig. 27 Therapy devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Negative pressure Wound Therapy market, 2018 - 2030 (USD Million)
  • Fig. 29 Ultrasound therapy market, 2018 - 2030 (USD Million)
  • Fig. 30 Antibiotic medications market, 2018 - 2030 (USD Million)
  • Fig. 31 Others market, 2018 - 2030 (USD Million)
  • Fig. 32 US diabetic foot ulcer treatment market: Ulcer type outlook and key takeaways
  • Fig. 33 US diabetic foot ulcer treatment market: Ulcer type movement analysis
  • Fig. 34 Neuropathic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 35 Ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 36 Neuro-ischemic ulcers market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. diabetic foot ulcer treatment market: End Use outlook and key takeaways
  • Fig. 38 U.S. diabetic foot ulcer treatment market: End Use movement analysis
  • Fig. 39 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 40 Ambulatory surgery centre market, 2018 - 2030 (USD Million)
  • Fig. 41 Homecare market, 2018 - 2030 (USD Million)
  • Fig. 42 Heat map analysis
  • Fig. 43 Market participant categorization
  • Fig. 44 U.S. diabetic foot ulcer treatment market share analysis, 2023
  • Fig. 45 Strategy framework